Insights on drafting pharmaceutical patents from the Supreme People’s Court’s Annual Report of Intellectual Property Cases
By Cecilia Lou, Yao Di and Shirley Sun
In April 2013, the Supreme People’s Court (SPC) issued the Annual Report of Intellectual Property Cases (Annual Report), which included 34 typical intellectual property and competition cases from 2012 and summed up 37 legal issues with universal significance. To assist pharmaceutical enterprises in drafting patent applications we have summarised the pharmaceutical patent cases in the Annual Report.
The Supreme Court held that: ‘[c]lose-ended claims should be generally construed as compromising indicated compositions only and exclude other ingredients, though impurities are allowed within normal amounts. However, excipients are not impurities. If the patentee chose a close-ended claim, he clearly considered that any unmentioned component is out of the protection scope of the patent right. Moreover, in this situation the doctrine of equivalents of judging different technical features should no longer be applied.’
The patent named ‘Adenosine triphosphate disodium and magnesium chloride frozen powder injection and its manufacturing method with an application no. 200410024515.1. There was a close-ended claim 2, which sought protection of a freeze-dried powder injection, comprising adenosine triphosphate disodium and magnesium chloride, with a weight ratio of 100mg to 32mg…
If you are registered and logged in to the site, click on the link below to read the rest of the King & Wood Mallesons briefing. If not, please register or sign in with your details below.
News from King & Wood Mallesons
News from The Lawyer
Briefings from King & Wood Mallesons
Principals and contractors need to be aware that in not registering security interests under the PPSA 2009, they may risk serious consequences.
The New Companies Ordinance (NCO) will come into effect on 3 March 2014. It includes changes that affect the way documents may be executed.
Analysis from The Lawyer
Shanghai’s ground-breaking Pilot Free Trade Zone could mark the beginning of the long-awaited liberalisation of China’s legal services sector.
Hong Kong IPO activity is hotting up again, but UK legal stalwarts are looking over their shoulders as US rivals make up ground fast